Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
about
Personalized medicine in major depressive disorder -- opportunities and pitfallsStress-Related Immune Markers in Depression: Implications for TreatmentA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueN-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidenceMass spectrometry for the detection of potential psychiatric biomarkersRisk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkersData mining EEG signals in depression for their diagnostic valueBiomarkers in pediatric depressionAlterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.Biomarkers of threat and reward sensitivity demonstrate unique associations with risk for psychopathologyActive behavioral coping alters the behavioral but not the endocrine response to stressVEGF-related polymorphisms identified by GWAS and risk for major depression.Dehydroepiandrosterone Sulfate Level Varies Nonlinearly with Symptom Severity in Major Depressive Disorder.Biomarkers for depression: recent insights, current challenges and future prospects.MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.Epigenetic mechanisms of depression and antidepressant actionMulti-scale motility amplitude associated with suicidal thoughts in major depressionErbB3 mRNA leukocyte levels as a biomarker for major depressive disorderInflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.Towards automated detection of depression from brain structural magnetic resonance images.Assessing neurocognitive function in psychiatric disorders: a roadmap for enhancing consensus.Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.Peptides from adipose tissue in mental disordersReduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice.Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.The inflammasome: pathways linking psychological stress, depression, and systemic illnessesSignaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.Long Term Hippocampal and Cortical Changes Induced by Maternal Deprivation and Neonatal Leptin Treatment in Male and Female Rats.Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression.Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol.Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depressionBlunted neural response to rewards as a vulnerability factor for depression: Results from a family studyOxidative stress and glutathione response in tissue cultures from persons with major depressionGlucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment
P2860
Q24170133-CBF62D35-77F7-43AC-88CA-474205E601B0Q26771607-1D4BFB7A-41EF-47AE-AC30-0FAAB3C6F4E0Q26786354-E9BDD44D-69B3-4153-A985-D6BE7E8D6592Q26827833-1AF063A2-D759-4282-97BC-2E890EEE8D4FQ26849307-3A11A4ED-F7B1-4E8E-A906-61D13B88FFD0Q26852637-D866B07A-EEE9-437D-BAE4-B1D1DA49E5E3Q27023402-86717F3A-9771-49B8-AD07-7E840A281E3CQ27307952-F0C1F16E-F0C4-43D8-BE37-9533E2599447Q28389366-88535A92-C471-4C46-BB7E-80ABF2FBF30CQ30372214-F2173FBB-1DE8-406C-B354-DA4C9723E53AQ30433643-78F6ED93-74CC-43F6-A96D-6D7A7C6BB0D1Q30446697-F1803042-F2DF-4D4A-A86D-E9263B345AB5Q33635586-5F538AF4-C225-4487-81AA-CA55347A436DQ33662855-A2A44FCF-DB40-4247-9091-57EA356C34ABQ33704099-F13606D6-A124-4A25-B146-1788C97C432AQ33815733-8534138C-B21E-48B8-AE08-9135ECF0D825Q33864410-17A98CCD-82FC-4940-869A-9A25B3BF8C27Q34302493-E61355C7-54DC-4014-A942-48306913040FQ34305724-5A44244A-7C35-4B2D-8CD7-B1A7198AA8EAQ34417778-3E18768F-17A6-492E-948F-5BE57530A618Q34468355-419EF657-5481-4BE0-9BDB-F91FB6FF5126Q34556789-34372E61-8836-477C-B3C5-45CAD6BD78F8Q34603013-D3811DF6-0B87-418F-9ED4-CC44EF321791Q34624634-7CC44002-F8AD-423C-AE73-AA8C98C3C91AQ34661281-5D2A7C94-A9B3-4B18-AA83-18382EC9887AQ34761266-A8518619-9F32-4397-9E83-7D6469F65669Q34965754-7875E2AA-79C1-4B15-BCA8-F3DB9FBE005DQ35006487-E7C0E491-83CF-4305-A59D-6686AD982327Q35535322-C133C361-7033-4A89-9BD9-D80EAC55DBC2Q35592049-FBCD8F69-78DE-4BC5-A415-CCDCF07A783EQ35754079-9627E087-4408-4C26-AC32-C860C6936E56Q35779861-FD757649-929E-4EF0-841C-034BE7D1E526Q35913907-7342C916-FCC8-4359-91AA-8885150AC21BQ36032426-16AEFF2C-3947-459D-91AE-FA7C9EFB67CAQ36043319-4430381F-7A21-4CC1-A805-FAB2EF7209D9Q36079041-4648B423-805C-414B-AB02-37F446B91C69Q36279126-5156830F-A03F-4803-AA52-E2D8722A5241Q36315791-5ADD3528-2DA0-4B50-935A-CF0CA306FE8AQ36345928-EB4B4EB0-F29D-42A9-8B32-0817B84A340EQ36610037-2EB61192-69CD-45A4-A769-243C1C2F57AA
P2860
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@ast
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@en
type
label
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@ast
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@en
prefLabel
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@ast
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@en
P2093
P2860
P356
P1476
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
@en
P2093
Heath D Schmidt
Richard C Shelton
Ronald S Duman
P2860
P2888
P304
P356
10.1038/NPP.2011.151
P407
P577
2011-08-03T00:00:00Z